FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978329574> ?p ?o ?g. }

• W1978329574 endingPage "359" @default.
• W1978329574 startingPage "350" @default.
• W1978329574 abstract "Background/Aims: Advanced glycation end products (AGEs) are involved in diabetic nephropathy. The AGE inhibitor pyridoxamine (PM) is renoprotective in experimental chronic allograft nephropathy supporting its potential in non-diabetic renal damage. Methods: We studied the effects of PM in adriamycin nephropathy (AN; 1.5 mg/kg i.v.). Six weeks after disease induction, treatment started with vehicle (VEH), lisinopril (ACEi; 75 mg/l drinking water), PM (2 g/l) and PM + lisinopril (PM/ACEi) (n = 12 per group) for 18 weeks. Age-matched healthy rats (n = 6) served as controls (CON). Results: ACEi reduced proteinuria, blood pressure, and renal damage. PM gradually increased blood pressure and not affected proteinuria. In PM/ACEi the antiproteinuric and blood pressure-lowering effects of ACEi were abrogated during long-term treatment. Remarkably, creatinine, focal glomerulosclerosis and interstitial fibrosis were considerably increased under PM/ACEi. Pronounced hypercholesterolemia, which occurred in both PM-treated groups, was accompanied by marked glomerular lipid deposition. Conclusion: PM was not renoprotective in AN. By contrast, renal damage was aggravated when PM was combined with ACEi. Despite the fact that there is no current evidence that these findings apply to the drug as used in human diabetic nephropathy, we emphasize the importance of close monitoring of blood pressure, lipids and possible direct toxic effects in future studies with PM in renal patients, especially when combining PM with ACEi." @default.
• W1978329574 created "2016-06-24" @default.
• W1978329574 creator A5003792811 @default.
• W1978329574 creator A5010367070 @default.
• W1978329574 creator A5019886164 @default.
• W1978329574 date "2008-01-01" @default.
• W1978329574 modified "2023-09-27" @default.
• W1978329574 title "Adverse Renal Effects of the AGE Inhibitor Pyridoxamine in Combination with ACEi in Non-Diabetic Adriamycin-Induced Renal Damage in Rats" @default.
• W1978329574 cites W1964586920 @default.
• W1978329574 cites W1968299608 @default.
• W1978329574 cites W1978657102 @default.
• W1978329574 cites W1990313130 @default.
• W1978329574 cites W2011955651 @default.
• W1978329574 cites W2016852654 @default.
• W1978329574 cites W2017959010 @default.
• W1978329574 cites W2038912720 @default.
• W1978329574 cites W2055063375 @default.
• W1978329574 cites W2055876879 @default.
• W1978329574 cites W2057454618 @default.
• W1978329574 cites W2064901107 @default.
• W1978329574 cites W2067165584 @default.
• W1978329574 cites W2068793587 @default.
• W1978329574 cites W2075525736 @default.
• W1978329574 cites W2085254992 @default.
• W1978329574 cites W2088147739 @default.
• W1978329574 cites W2090969480 @default.
• W1978329574 cites W2093308211 @default.
• W1978329574 cites W2104632394 @default.
• W1978329574 cites W2107512014 @default.
• W1978329574 cites W2112461161 @default.
• W1978329574 cites W2114283061 @default.
• W1978329574 cites W2116796322 @default.
• W1978329574 cites W2123032423 @default.
• W1978329574 cites W2128578030 @default.
• W1978329574 cites W2136463047 @default.
• W1978329574 cites W2140491925 @default.
• W1978329574 cites W2145989568 @default.
• W1978329574 cites W2152741096 @default.
• W1978329574 cites W2158221621 @default.
• W1978329574 cites W2160382989 @default.
• W1978329574 cites W2160751100 @default.
• W1978329574 cites W2395264365 @default.
• W1978329574 cites W2409071315 @default.
• W1978329574 cites W2414315675 @default.
• W1978329574 cites W2416558052 @default.
• W1978329574 cites W2004252049 @default.
• W1978329574 doi "https://doi.org/10.1159/000173253" @default.
• W1978329574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19018148" @default.
• W1978329574 hasPublicationYear "2008" @default.
• W1978329574 type Work @default.
• W1978329574 sameAs 1978329574 @default.
• W1978329574 citedByCount "2" @default.
• W1978329574 countsByYear W19783295742014 @default.
• W1978329574 crossrefType "journal-article" @default.
• W1978329574 hasAuthorship W1978329574A5003792811 @default.
• W1978329574 hasAuthorship W1978329574A5010367070 @default.
• W1978329574 hasAuthorship W1978329574A5019886164 @default.
• W1978329574 hasConcept C126322002 @default.
• W1978329574 hasConcept C126894567 @default.
• W1978329574 hasConcept C134018914 @default.
• W1978329574 hasConcept C159641895 @default.
• W1978329574 hasConcept C27016395 @default.
• W1978329574 hasConcept C2776940978 @default.
• W1978329574 hasConcept C2777390665 @default.
• W1978329574 hasConcept C2777880890 @default.
• W1978329574 hasConcept C2778428028 @default.
• W1978329574 hasConcept C2778653478 @default.
• W1978329574 hasConcept C2779561371 @default.
• W1978329574 hasConcept C2779611605 @default.
• W1978329574 hasConcept C2779922275 @default.
• W1978329574 hasConcept C2780091579 @default.
• W1978329574 hasConcept C2780306776 @default.
• W1978329574 hasConcept C2781184683 @default.
• W1978329574 hasConcept C3019288012 @default.
• W1978329574 hasConcept C555293320 @default.
• W1978329574 hasConcept C71924100 @default.
• W1978329574 hasConcept C84393581 @default.
• W1978329574 hasConceptScore W1978329574C126322002 @default.
• W1978329574 hasConceptScore W1978329574C126894567 @default.
• W1978329574 hasConceptScore W1978329574C134018914 @default.
• W1978329574 hasConceptScore W1978329574C159641895 @default.
• W1978329574 hasConceptScore W1978329574C27016395 @default.
• W1978329574 hasConceptScore W1978329574C2776940978 @default.
• W1978329574 hasConceptScore W1978329574C2777390665 @default.
• W1978329574 hasConceptScore W1978329574C2777880890 @default.
• W1978329574 hasConceptScore W1978329574C2778428028 @default.
• W1978329574 hasConceptScore W1978329574C2778653478 @default.
• W1978329574 hasConceptScore W1978329574C2779561371 @default.
• W1978329574 hasConceptScore W1978329574C2779611605 @default.
• W1978329574 hasConceptScore W1978329574C2779922275 @default.
• W1978329574 hasConceptScore W1978329574C2780091579 @default.
• W1978329574 hasConceptScore W1978329574C2780306776 @default.
• W1978329574 hasConceptScore W1978329574C2781184683 @default.
• W1978329574 hasConceptScore W1978329574C3019288012 @default.
• W1978329574 hasConceptScore W1978329574C555293320 @default.
• W1978329574 hasConceptScore W1978329574C71924100 @default.
• W1978329574 hasConceptScore W1978329574C84393581 @default.
• W1978329574 hasIssue "5" @default.

• next